Pulmonx Corp
(LUNG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 148,711 | 188,306 | 198,934 | 209,514 | 231,792 |
| Marketable Securities | 31,561 | 11,774 | 10,774 | 9,784 | N/A |
| Receivables | 6,562 | 6,919 | 6,884 | 5,119 | 4,228 |
| Inventories | 16,285 | 14,985 | 13,401 | 11,916 | 10,741 |
| TOTAL | $208,002 | $227,644 | $233,084 | $239,344 | $249,989 |
| Non-Current Assets | |||||
| PPE Net | 4,814 | 4,703 | 2,773 | 1,799 | 1,474 |
| Investments And Advances | 10,941 | 2,798 | 2,024 | 2,498 | 0 |
| Intangibles | 2,610 | 2,641 | 2,672 | 2,703 | 2,733 |
| Other Non-Current Assets | 8,806 | 9,032 | 8,387 | 8,926 | 9,512 |
| TOTAL | $27,171 | $19,174 | $15,856 | $15,926 | $13,719 |
| Total Assets | $235,173 | $246,818 | $248,940 | $255,270 | $263,708 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,306 | 1,889 | 472 | N/A |
| Accounts payable and accrued liabilities | 1,582 | 4,434 | 2,156 | 1,826 | 1,472 |
| Accrued Expenses | 13,366 | 12,374 | 10,499 | 9,756 | 8,651 |
| Other current liabilities | 91 | N/A | N/A | N/A | N/A |
| TOTAL | $17,550 | $22,217 | $16,326 | $14,023 | $12,526 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,324 | 13,547 | 14,938 | 16,329 | 16,804 |
| Deferred Revenues | 163 | 157 | 85 | 75 | 71 |
| Other Non-Current Liabilities | 7,023 | 8,156 | 7,685 | 8,232 | 8,182 |
| TOTAL | $24,384 | $21,773 | $22,694 | $24,632 | $25,048 |
| Total Liabilities | $41,934 | $43,990 | $39,020 | $38,655 | $37,574 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,019 | 36,839 | 36,690 | 36,248 | 35,690 |
| Common Shares | 37 | 37 | 36 | 36 | 36 |
| Retained earnings | -291,395 | -278,389 | -267,156 | -254,779 | -242,734 |
| Other shareholders' equity | 1,712 | 1,544 | 1,479 | 1,410 | 1,685 |
| TOTAL | $193,239 | $202,828 | $209,920 | $216,615 | $226,134 |
| Total Liabilities And Equity | $235,173 | $246,818 | $248,940 | $255,270 | $263,708 |